Table 2.

Distribution of diabetic patients with high and low peripheral arterial stiffness in subgroup analysis

Characteristics	Low PAS group (%)	High PAS group (%)	P
Gender
Male	17 (56.7)	34 (45.3)	0.294
Female	13 (43.3)	41 (54.7)
Hypertension
No	22 (73.3)	24 (32.0)	<0.001*
Yes	8 (26.7)	51 (68.0)
Statins
No	16 (53.3)	38 (50.7)	0.805
Yes	14 (46.7)	37 (49.3)
Fibrates
No	29 (96.7)	71 (94.7)	0.664
Yes	1 (3.3)	4 (5.3)
Metformin
No	17 (56.7)	30 (40.0)	0.121
Yes	13 (43.3)	45 (60.0)
Sulfonylureas
No	13 (43.3)	36 (48.0)	0.665
Yes	17 (56.7)	39 (52.0)
DDP-4 inhibitors
No	9 (30.0)	34 (45.3)	0.149
Yes	21 (70.0)	41 (54.7)
Thiazolidinediones
No	30 (100.0)	74 (98.7)	0.525
Yes	0	1 (1.3)
Insulin
No	26 (86.7)	54 (72.0)	0.111
Yes	4 (13.3)	21 (28.0)

*P < 0.05 was considered statistically significant. Data are expressed as n (%) of patients. Analysis was done using the Chi-square test. PAS: Peripheral arterial stiffness, DDP-4: Dipeptidyl peptidase 4